To explore the clinical effects of aescin combined with ceftriaxone in the treatment of bacterial meningitis (BM).
A prospective study was conducted on 80 patients with BM admitted to Ningguo people's hospital from April 2019 to April 2021. According to the random lottery method, they were divided into observation group and control group at a ratio of 1∶1, with 40 cases in each group. The control group was treated with ceftriaxone, and the observation group was treated with aescin combined with ceftriaxone. We would compare the efficacy, time of symptom disappearance, inflammatory factors before and after treatment [procalcitonin (PCT), interleukin-6 (IL-6), C-reactive protein (CRP), soluble vascular cell adhesion molecule 1 (sVCAM-1)], oxidative stress indicators [superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), malondialdehyde (MDA)], brain edema index [aquaporin 4 (AQP4), S-100 calcium binding protein (S-100B)] and treatment the incidence of adverse reactions during the period.
The total effective rate of the observation group was 92.50%, higher than that of the control group 75.00% (P<0.05). The observation group had less time of fever resolution, disappearance of intracranial hypertension, recovery of consciousness, and the disappearance of convulsions were shorter time than those in the control group (P<0.05). The levels of serum PCT, IL-6, CRP, sVCAM-1, AQP4, and S-100B in the observation group were lower than those of the control group (P<0.05). After treatment, the serum SOD and GSH-Px levels in the observation group were higher than those in the control group, and the MDA level was lower than that in the control group (P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05).
Aescin combined with ceftriaxone has a significant effect in the treatment of BM patients, which can effectively promote the improvement of symptoms, reduce inflammation and oxidative stress in the body, relieve cerebral edema with high safety.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |